Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome

Area of Science:

• Microbiology
• Pharmacology
• Immunology

Background:

• Prolonged opioid use leads to analgesic tolerance, overdose, and death.
• The precise mechanisms driving morphine analgesic tolerance remain unclear.
• Gut microbiota alterations are increasingly implicated in drug response and tolerance.

Purpose of the Study:

• To investigate the role of gut microbiota in morphine analgesic tolerance.
• To identify specific microbial changes associated with morphine tolerance.
• To evaluate the therapeutic potential of probiotics in mitigating morphine tolerance.

Main Methods:

• Utilized germfree (GF) mice and pan-antibiotic treatment to eliminate gut microbiota.
• Assessed morphine analgesic tolerance in GF and conventionally-raised mice.
• Reconstituted GF mice with fecal microbiota and evaluated tolerance.
• Analyzed microbial composition, focusing on Bifidobacteria and Lactobacillaeae.
• Administered probiotics enriched with specific bacterial communities to morphine-treated mice.

Main Results:

• Morphine analgesic tolerance was significantly attenuated in germfree and antibiotic-treated mice.
• Reconstitution with naïve fecal microbiota restored morphine analgesic tolerance.
• Tolerance was linked to gut dysbiosis, characterized by depletion of Bifidobacteria and Lactobacillaeae.
• Probiotic administration, enriched with these depleted bacteria, attenuated morphine analgesic tolerance.

Conclusions:

• Gut microbiota play a critical role in the development of morphine analgesic tolerance.
• Morphine-induced gut dysbiosis, particularly depletion of Bifidobacteria and Lactobacillaeae, contributes to tolerance.
• Probiotic therapy represents a promising strategy to prolong morphine efficacy and mitigate tolerance.
• A proposed mechanism involves morphine-induced gut dysbiosis, barrier disruption, inflammation, and subsequent tolerance.